Recent advances in polymeric microspheres for parenteral drug delivery part 1

Expert Opinion on Drug Delivery

Volumn 9, Issue 9, 2012, Pages 1161-1176

  Mao, Shirui ^a   Guo, Chunqiang ^b   Shi, Yi ^b   Li, Luk Chiu ^b  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b ABBOTT LABORATORIES   (United States)

Author keywords

Microsphere characterization; Microsphere formulations; Parenteral drug delivery; Polymeric microspheres

Indexed keywords

ALGAL EXTRACT; ALGINIC ACID; CHITOSAN; DEXTRAN; DEXTRAN DERIVATIVE; DOXORUBICIN; EXENDIN 4; GELATIN; HUMAN GROWTH HORMONE; HYALURONIC ACID; LEUPRORELIN; MACROGOL; MICROSPHERE; NALTREXONE; OCTREOTIDE; ORGANOPHOSPHATE; POLY(3 HYDROXYBUTYRIC ACID); POLYANHYDRIDE; POLYCAPROLACTONE; POLYCARBONATE; POLYGLACTIN; POLYGLYCOLIDE; POLYLACTIDE; POLYMER; POLYVINYL ALCOHOL; RESPERIDAL; RISPERIDONE; SANTOSTATIN; STARCH; TETANUS TOXOID; TRIPTORELIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITROL;

ACROMEGALY; ALCOHOLISM; ARTIFICIAL EMBOLISM; BIODEGRADABILITY; BIOEQUIVALENCE; BIPOLAR DISORDER; BOVINE SPONGIFORM ENCEPHALOPATHY; BRAIN ISCHEMIA; CANCER PALLIATIVE THERAPY; CARCINOID; CATALYSIS; CONFOCAL LASER MICROSCOPY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; EMULSION; ENDOMETRIOSIS; GEL PERMEATION CHROMATOGRAPHY; GLASS TRANSITION TEMPERATURE; HUMAN; HYDROPHILICITY; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MATHEMATICAL MODEL; MICROENCAPSULATION; MICROSCOPY; MICROTECHNOLOGY; MOLECULAR WEIGHT; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OPIATE ADDICTION; PARTICLE SIZE; PH; POROSITY; PRECOCIOUS PUBERTY; PROSTATE CANCER; QUALITY CONTROL; REVIEW; SCANNING ELECTRON MICROSCOPY; SCHIZOPHRENIA; STATIC ELECTRICITY; SUSTAINED DRUG RELEASE; VIPOMA; X RAY DIFFRACTION; ZETA POTENTIAL;

ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; INFUSIONS, PARENTERAL; MICROSPHERES; POLYMERS;

EID: 84865314548     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2012.709844     Document Type: Review

References (109)

1. Freiberg S, Zhu XX. Polymer microspheres for controlled drug release. Int J Pharm 2004;282(1-2):1-18 (Pubitemid 39178480)
2. Tamber H, Johansen P, Merkle HP, et al. Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv Drug Deliv Rev 2005;57(3):357-76 (Pubitemid 39555502)
3. Stovall K. Dissertation: Investigation of properties affecting controlled release of macromolecules from PLGA microspheres. University of Illinois at Urbana-Champaign; 2009.
4. Ding AG, Schwendeman SP. Acidic microclimate pH distribution in PLGA microspheres monitored by confocal laser scanning microscopy. Pharm Res 2008;25(9):2041-52
5. Estey T, Kang J, Schwendeman SP, et al. BSA degradation under acidic conditions: a model for protein instability during release from PLGA delivery systems. J Pharm Sci 2006;95(7):1626-39 (Pubitemid 44049129)
6. Jiang W, Schwendeman SP. Stabilization of tetanus toxoid encapsulated in PLGA microspheres. Mol Pharm 2008;5(5):808-17
7. Mi FL, Shyu SS, Lin YM, et al. Chitin/PLGA blend microspheres as a biodegradable drug delivery system: a new delivery system for protein. Biomaterials 2003;24(27):5023-36
8. Sinha VR, Bansal K, Kaushik R, et al. Poly-epsilon-caprolactone microspheres and nanospheres: an overview. Int J Pharm 2004;278(1):1-23
9. Aslan S, Calandrelli L, Laurienzo P, et al. Poly (D, L-lactic acid)/poly (-caprolactone) blend membranes: preparation and morphological characterisation. J Mater Res 2000;35(7):1615-22 (Pubitemid 30589897)
10. Mundargi RC, Srirangarajan S, Agnihotri SA, et al. Development and evaluation of novel biodegradable microspheres based on poly (d, l-lactide-co-glycolide) and poly (epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies. J Control Release 2007;119(1):59-68 (Pubitemid 46561539)
11. Dash TK, Konkimalla VB. Poly-(caprolactone) based formulations for drug delivery and tissue engineering: a review. J Control Release 2012; 158(1):15-33
12. Jain JP, Modi S, Domb AJ, et al. Role of polyanhydrides as localized drug carriers. J Control Release 2005;103(3):541-63 (Pubitemid 40476140)
13. Kumar N, Langer RS, Domb AJ. Polyanhydrides: an overview. Adv Drug Deliv Rev 2002;54(7):889-910
14. Katti DS, Lakshmi S, Langer R, et al. Toxicity, biodegradation and elimination of polyanhydrides. Adv Drug Deliv Rev 2002;54(7):933-61
15. Gunatillake P, Mayadunne R, Adhikari R. Recent developments in biodegradable synthetic polymers. Biotechnol Annu Rev 2006;12:301-47 (Pubitemid 44509804)
16. Peng D, Huang K, Liu Y, et al. Preparation of novel polymeric microspheres for controlled release of finasteride. Int J Pharm 2007; 342(1-2):82-6 (Pubitemid 47259330)
17. Hu B, Tu YY, Yan GP, et al. Polycarbonate microspheres containing mitomycin C and magnetic powders as potential hepatic carcinoma therapeutics. Colloids Surf B Biointerfaces 2011; 84(2):550-5
18. Joseph NJ, Lakshmi S, Jayakrishnan A. A floating-type oral dosage form for piroxicam based on hollow polycarbonate microspheres: in vitro and in vivo evaluation in rabbits. J Control Release 2002;79(1-3):71-9 (Pubitemid 34164162)
19. Heller J, Barr J, Ng SY, et al. Poly(ortho esters): synthesis, characterization, properties and uses. Adv Drug Deliv Rev 2002;54(7):1015-39
20. Chiellini F, Piras AM, Errico C, et al. Micro/nanostructured polymeric systems for biomedical and pharmaceutical applications. Nanomedicine (Lond) 2008;3(3):367-93 (Pubitemid 351827313)
21. Deng JS, Li L, Tian Y, et al. In vitro characterization of polyorthoester microparticles containing bupivacaine. Pharm Dev Technol 2003;8(1):31-8 (Pubitemid 36337476)
22. Wang C, Ge Q, Ting D, et al. Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines. Nat Mater 2004;3(3):190-6
23. Wang S, Wan AC, Xu X, et al. A new nerve guide conduit material composed of a biodegradable poly(phosphoester). Biomaterials 2001;22(10):1157-69 (Pubitemid 32229940)
24. Lakshmi S, Katti DS, Laurencin CT. Biodegradable polyphosphazenes for drug delivery applications. Adv Drug Deliv Rev 2003;55(4):467-82 (Pubitemid 36423300)
25. Zhao Z, Wang J, Mao HQ, et al. Polyphosphoesters in drug and gene delivery. Adv Drug Deliv Rev 2003;55(4):483-99 (Pubitemid 36423301)
26. Xu X, Yee WC, Hwang PY, et al. Peripheral nerve regeneration with sustained release of poly(phosphoester) microencapsulated nerve growth factor within nerve guide conduits. Biomaterials 2003;24(13):2405-12 (Pubitemid 36434060)
27. Shishatskaya EI, Voinova ON, Goreva AV, et al. Biocompatibility of polyhydroxybutyrate microspheres: in vitro and in vivo evaluation. J Mater Sci Mater Med 2008;19(6):2493-502
28. Salman MA, Sahin A, Onur MA, et al. Tramadol encapsulated into polyhydroxybutyrate microspheres: in vitro release and epidural analgesic effect in rats. Acta Anaesthesiol Scand 2003;47(8):1006-12 (Pubitemid 37013777)
29. Mao S, Sun W, Kissel T. Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Deliv Rev 2010; 62(1):12-27
30. Sinha VR, Singla AK, Wadhawan S, et al. Chitosan microspheres as a potential carrier for drugs. Int J Pharm 2004;274(1-2):1-33 (Pubitemid 38457003)
31. Guerrero S, Teijón C, Muñiz E, et al. Characterization and in vivo evaluation of ketotifen-loaded chitosan microspheres. Carbohydr Polym 2010;79(4):1006-13
32. Hejazi R, Amiji M. Stomach-specific anti-H. pylori therapy. I: Preparation and characterization of tetracyline-loaded chitosan microspheres. Int J Pharm 2002;235(1-2):87-94 (Pubitemid 34185439)
33. George M, Abraham TE. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan-a review. J Control Release 2006;114(1):1-14 (Pubitemid 44131680)
34. Hori Y, Winans AM, Irvine DJ. Modular injectable matrices based on alginate solution/microsphere mixtures that gel in situ and co-deliver immunomodulatory factors. Acta Biomater 2009;5(4):969-82
35. Matricardi P, Meo CD, Coviello T, et al. Recent advances and perspectives on coated alginate microspheres for modified drug delivery. Expert Opin Drug Deliv 2008;5(4):417-25 (Pubitemid 351721721)
36. Tafaghodi M, Sajadi Tabassi SA, Jaafari MR. Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN. Int J Pharm 2006;319(1-2):37-43 (Pubitemid 44051800)
37. Liao YH, Jones SA, Forbes B, et al. Hyaluronan: pharmaceutical characterization and drug delivery. Drug Deliv 2005;12(6):327-42 (Pubitemid 41572107)
38. Jiang D, Liang J, Noble PW. Hyaluronan as an immune regulator in human diseases. Physiol Rev 2011;91(1):221-64
39. Yun YH, Goetz DJ, Yellen P, et al. Hyaluronan microspheres for sustained gene delivery and site-specific targeting. Biomaterials 2004;25(1):147-57 (Pubitemid 37324408)
40. Chung HJ, Jung JS, Park TG. Fabrication of adipose-derived mesenchymal stem cell aggregates using biodegradable porous microspheres for injectable adipose tissue regeneration. J Biomater Sci Polym Ed 2010
41. Nitta N, Ohta S, Tanaka T, et al. Gelatin microspheres: initial clinical experience for the transcatheter arterial embolization. Eur J Radiol 2008;67(3):536-40
42. Jin YC, Kim SW, Cheng F, et al. The effect of biodegradable gelatin microspheres on the neuroprotective effects of high mobility group box 1 A box in the postischemic brain. Biomaterials 2011;32(3):899-908
43. Karim AA, Bhat R. Gelatin alternatives for the food industry: recent developments, challenges and prospects. Trends Food Sci Tech 2008;19(12):644-56
44. Shiba H, Okamoto T, Futagawa Y, et al. Adenovirus vector-mediated gene transfer using degradable starch microspheres for hepatocellular carcinoma in rats. J Surg Res 2006;133(2):193-6 (Pubitemid 43786229)
45. Selek H, Sahin S, Kas HS, et al. Formulation and characterization of formaldehyde cross-linked degradable starch microspheres containing terbutaline sulfate. Drug Dev Ind Pharm 2007;33(2):147-54 (Pubitemid 46568305)
46. Morise Z, Sugioka A, Kato R, et al. Transarterial chemoembolization with degradable starch microspheres, irinotecan, and mitomycin-C in patients with liver metastases. J Gastrointest Surg 2006;10(2):249-58 (Pubitemid 43187188)
47. Diwan M, Khar RK, Talwar GP. Tetanus toxoid loaded 'preformed microspheres' of cross-linked dextran. Vaccine 2001;19(28-29):3853-9 (Pubitemid 32566306)
48. Liu Z, Ballinger JR, Rauth AM, et al. Delivery of an anticancer drug and a chemosensitizer to murine breast sarcoma by intratumoral injection of sulfopropyl dextran microspheres. J Pharm Pharmacol 2003;55(8):1063-73 (Pubitemid 36998646)
49. Vlugt-Wensink KD, de Vrueh R, Gresnigt MG, et al. Preclinical and clinical in vitro in vivo correlation of an hGH dextran microsphere formulation. Pharm Res 2007;24(12):2239-48 (Pubitemid 350060716)
50. Stenekes RJ, Loebis AE, Fernandes CM, et al. Degradable dextran microspheres for the controlled release of liposomes. Int J Pharm 2001;214(1-2):17-20 (Pubitemid 32244071)
51. Mao S, Xu J, Cai C, et al. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres. Int J Pharm 2007; 334(1-2):137-48 (Pubitemid 46400322)
52. Feng L, Qi XR, Zhou XJ, et al. Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres. J Control Release 2006;112(1):35-42
53. Alexis F. Factors affecting the degradation and drug-release mechanism of poly(lactic acid) and poly[(lactic acid)-co-(glycolic acid)]. Polym Int 2005;54(1):36-46 (Pubitemid 40032749)
54. Chakravarthi SS, Robinson DH. Enhanced cellular association of paclitaxel delivered in chitosan-PLGA particles. Int J Pharm 2011;409(1-2):111-20
55. Meng ZX, Zheng W, Li L, et al. Fabrication, characterization and in vitro drug release behavior of electrospun PLGA/chitosan nanofibrous scaffold. Mater Chem Phys 2011;125(3):606-11
56. Ruan G, Feng SS, Li QT. Effects of material hydrophobicity on physical properties of polymeric microspheres formed by double emulsion process. J Control Release 2002;84(3):151-60 (Pubitemid 35439142)
57. Hamishehkar H, Emami J, Najafabadi AR, et al. The effect of formulation variables on the characteristics of insulin-loaded poly (lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method. Colloids Surf B Biointerfaces 2009;74(1):340-9
58. Wang X, Xu H, Zhao Y, et al. Poly (lactide-co-glycolide) encapsulated hydroxyapatite microspheres for sustained release of doxycycline. Mater Sci Eng B 2012;177(4):367-72
59. Garbayo E, Ansorena E, Lanciego JL, et al. Sustained release of bioactive glycosylated glial cell-line derived neurotrophic factor from biodegradable polymeric microspheres. Eur J Pharm Biopharm 2008;69(3):844-51
60. Chu DF, Fu XQ, Liu WH, et al. Pharmacokinetics and in vitro and in vivo correlation of huperzine A loaded poly(lactic-co-glycolic acid) microspheres in dogs. Int J Pharm 2006;325(1-2):116-23
61. Mao S, Shi Y, Li L, et al. Effects of process and formulation parameters on characteristics and internal morphology of poly(d, l-lactide-co-glycolide) microspheres formed by the solvent evaporation method. Eur J Pharm Biopharm 2008;68(2):214-23
62. Jeong YI, Song JG, Kang SS, et al. Preparation of poly(DL-lactide-co- glycolide) microspheres encapsulating all-trans retinoic acid. Int J Pharm 2003;259(1-2):79-91
63. Choi HS, Seo SA, Khang G, et al. Preparation and characterization of fentanyl-loaded PLGA microspheres: in vitro release profiles. Int J Pharm 2002;234(1-2):195-203 (Pubitemid 34142624)
64. Yang YY, Chung TS, Ng NP. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials 2001;22(3):231-41
65. Frauke Pistel K, Breitenbach A, Zange-Volland R, et al. Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D, L-lactic-co-glycolic acid). J Control Release 2001;73(1):7-20 (Pubitemid 32406097)
66. Sandor M, Enscore D, Weston P, et al. Effect of protein molecular weight on release from micron-sized PLGA microspheres. J Control Release 2001; 76(3):297-311 (Pubitemid 32913438)
67. Freitas S, Merkle HP, Gander B. Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J Control Release 2005;102(2):313-32 (Pubitemid 40093756)
68. Ruan G, Ng JK, Feng SS. Effects of polymer, organic solvent and mixing strength on integrity of proteins and liposomes encapsulated in polymeric microspheres fabricated by the double emulsion process. J Microencapsul 2004;21(4):399-412 (Pubitemid 39377783)
69. Vandervoort J, Ludwig A. Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study. Int J Pharm 2002;238(1-2):77-92 (Pubitemid 34457877)
70. Sturesson C, Degling Wikingsson L. Comparison of poly(acryl starch) and poly(lactide-co-glycolide) microspheres as drug delivery system for a rotavirus vaccine. J Control Release 2000;68(3):441-50
71. Pradeesh TS, Sunny MC, Varma HK, et al. Preparation of microstructured hydroxyapatite microspheres using oil in water emulsions. Bull Mater Sci 2005;28(5):383-90 (Pubitemid 41335877)
72. Zhou YX, Li SL, Fu HL, et al. Fabrication and in vitro drug release study of microsphere drug delivery systems based on amphiphilic poly-alpha, beta-[N-(2-hydroxyethyl)-L-aspartamide]-g-poly(L-lactide) graft copolymers. Colloids Surf B Biointerfaces 2008;61(2):164-9
73. Street TO, Bolen DW, Rose GD. A molecular mechanism for osmolyte-induced protein stability. Proc Natl Acad Sci USA 2006;103(38):13997-4002 (Pubitemid 44488414)
74. Li M, Rouaud O, Poncelet D. Microencapsulation by solvent evaporation: state of the art for process engineering approaches. Int J Pharm 2008;363(1-2):26-39
75. Yang Y-Y, Chung T-S, Bai X-L, et al. Effect of preparation conditions on morphology and release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion method. Chem Eng Sci 2000;55(12):2223-36 (Pubitemid 30233954)
76. Pistel KF, Kissel T. Effects of salt addition on the microencapsulation of proteins using W/O/W double emulsion technique. J Microencapsul 2000;17(4):467-83 (Pubitemid 30420829)
77. Martinez-Sancho C, Herrero-Vanrell R, Negro S. Optimisation of aciclovir poly (D, L-lactide-co-glycolide) microspheres for intravitreal administration using a factorial design study. Int J Pharm 2004;273(1-2):45-56 (Pubitemid 38317039)
78. Cai C, Mao S, Germershaus O, et al. Influence of morphology and drug distribution on the release process of FITC-dextran-loaded microspheres prepared with different types of PLGA. J Microencapsul 2009;26(4):334-45
79. Kim TK, Yoon JJ, Lee DS, et al. Gas foamed open porous biodegradable polymeric microspheres. Biomaterials 2006;27(2):152-9
80. Kim HK, Chung HJ, Park TG. Biodegradable polymeric microspheres with "open/closed" pores for sustained release of human growth hormone. J Control Release 2006;112(2):167-74
81. Wang J, Wang BM, Schwendeman SP. Mechanistic evaluation of the glucose-induced reduction in initial burst release of octreotide acetate from poly(D, L-lactide-co-glycolide) microspheres. Biomaterials 2004;25(10):1919-27 (Pubitemid 38102267)
82. He J, Feng M, Zhou X, et al. Stabilization and encapsulation of recombinant human erythropoietin into PLGA. Int J Pharm 2011;416(1):69-76
83. Stivaktakis N, Nikou K, Panagi Z, et al. PLA and PLGA microspheres of beta-galactosidase: effect of formulation factors on protein antigenicity and immunogenicity. J Biomed Mater Res A 2004;70(1):139-48 (Pubitemid 38849821)
84. Sah H. Ethyl formate-alternative dispersed solvent useful in preparing PLGA microspheres. Int J Pharm 2000;195(1-2):103-13 (Pubitemid 30089495)
85. Yang Q, Owusu-Ababio G. Biodegradable progesterone microsphere delivery system for osteoporosis therapy. Drug Dev Ind Pharm 2000;26(1):61-70 (Pubitemid 30075303)
86. Blanco-Prieto M, Lecaroz C, Renedo M, et al. In vitro evaluation of gentamicin released from microparticles. Int J Pharm 2002;242(1-2):203-6
87. Barrow WW. Microsphere technology for chemotherapy of mycobacterial infections. Curr Pharm Des 2004; 10(26):3275-84 (Pubitemid 39276615)
88. Nijsen JF, van het Schip AD, Hennink WE, et al. Advances in nuclear oncology: microspheres for internal radionuclide therapy of liver tumours. Curr Med Chem 2002;9(1):73-82 (Pubitemid 34441017)
89. Liggins RT, Cruz T, Min W, et al. Intra-articular treatment of arthritis with microsphere formulations of paclitaxel: biocompatibility and efficacy determinations in rabbits. Inflamm Res 2004;53(8):363-72 (Pubitemid 39141750)
90. Reynolds RA, Stramski D, Wright VM, et al. Measurements and characterization of particle size distributions in coastal waters. J Geophys Res 2010; 115(C8):C08024
91. Burgess DJ, Duffy E, Etzler F, et al. Particle size analysis: AAPS workshop report, cosponsored by the food and drug administration and the United States Pharmacopeia. AAPS J 2004; 6(3):e20
92. Coccoli V, Luciani A, Orsi S, et al. Engineering of poly(epsilon- caprolactone) microcarriers to modulate protein encapsulation capability and release kinetic. J Mater Sci Mater Med 2008;19(4):1703-11 (Pubitemid 351388893)
93. Abdel-Fattah WI, Jiang T, El-Bassyouni Gel T, et al. Synthesis, characterization of chitosans and fabrication of sintered chitosan microsphere matrices for bone tissue engineering. Acta Biomater 2007;3(4):503-14 (Pubitemid 46865775)
94. Lamprecht A, Schafer U, Lehr CM. Structural analysis of microparticles by confocal laser scanning microscopy. AAPS PharmSciTech 2000;1(3):E17
95. van de Weert M, van 't Hof R, van der Weerd J, et al. Lysozyme distribution and conformation in a biodegradable polymer matrix as determined by FTIR techniques. J Control Release 2000;68(1):31-40 (Pubitemid 30409973)
96. Kim TH, Park TG. Critical effect of freezing/freeze-drying on sustained release of FITC-dextran encapsulated within PLGA microspheres. Int J Pharm 2004;271(1-2):207-14 (Pubitemid 38210098)
97. Ruan G, Feng SS. Preparation and characterization of poly(lactic acid)-poly (ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel. Biomaterials 2003;24(27):5037-44 (Pubitemid 37242983)
98. Li LC, Tian Y. Zeta potential. In: Swarbrick J, editors. Encyclopedia of pharmaceutical technology. 3rd edition. 2007; Volume 6 Set Informa Health USA Inc., 270 Madison Avenue, New York, NY 10016, p. 4117-28
99. Martinez-Sancho C, Herrero-Vanrell R, Negro S. Study of gamma-irradiation effects on aciclovir poly(D, L-lactic-co-glycolic) acid microspheres for intravitreal administration. J Control Release 2004;99(1):41-52 (Pubitemid 39165732)
100. Gupte A, Ciftci K. Formulation and characterization of Paclitaxel, 5-FU and Paclitaxel + 5-FU microspheres. Int J Pharm 2004;276(1-2):93-106 (Pubitemid 38542992)
101. Wang L, Chaw CS, Yang YY, et al. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly (ortho ester) and poly(ortho ester)/poly (D, L-lactide-co-glycolide) blend microspheres fabricated by spray drying. Biomaterials 2004;25(16):3275-82 (Pubitemid 38234788)
102. Sipos P, Szabó A, Eros I, et al. A DSC and Raman spectroscopic study of microspheres preparedwith polar cosolvents by different techniques. J Therm Anal Calorim 2008;94(1):109-18
103. Sipos P, Szucs M, Szabó A, et al. An assessment of the interactions between diclofenac sodium and ammonio methacrylate copolymer using thermal analysis and Raman spectroscopy. J Pharm Biomed Anal 2008;46(2):288-94 A review reporting the combined use of two physical methods in determining drug-polymer interaction.
104. Kumar R, Palmieri MJ Jr. Points to consider when establishing drug product specifications for parenteral microspheres. AAPS J 2010;12(1):27-32 A very good reference for setting specifications for microspheres intended for parenteral drug delivery.
105. Blanco-Prieto MJ, Campanero MA, Besseghir K, et al. Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres. J Control Release 2004;96(3):437-48 (Pubitemid 38553922)
106. Kim TH, Jiang HH, Park CW, et al. PEGylated TNF-related apoptosis-inducing ligand (TRAIL)-loaded sustained release PLGA microspheres for enhanced stability and antitumor activity. J Control Release 2011;150(1):63-9
107. Li Z, Li L, Liu Y, et al. Development of interferon alpha-2b microspheres with constant release. Int J Pharm 2011;410(1-2):48-53
108. Zolnik BS, Burgess DJ. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres. J Control Release 2008;127(2):137-45
109. Sun Y, Wang J, Zhang X, et al. Synchronic release of two hormonal contraceptives for about one month from the PLGA microspheres: in vitro and in vivo studies. J Control Release 2008;129(3):192-9